⨯

  • 22 Jan 21

ANGLE present at the Proactive One2One live virtual conference

ANGLE present at the Proactive One2One live virtual conference

ANGLE plc | AGL | 136 7.0 0.1%
Follow Company Follow Company

    • 11 views

 

Andrew Newland (CEO) & Ian Griffiths (FD) pitch to investors at the Proactive One2One live virtual conference. ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLE's proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via the share buttons below. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

FTSE lacks direction, US tech giants report thumping results as traders nervously await US Fed update

Companies: ANGLE plc

ANGLE aiming for FDA approval of Parsortix in third quarter

Companies: ANGLE plc

Angle (LON:AGL) Presenting at the Proactive One2One Virtual Forum

Companies: ANGLE plc

ANGLE PLC submits its flagship Parsortix liquid biopsy diagnostic to the FDA

Companies: ANGLE plc

ANGLE announce first large-scale pharma services contract for Parsortix liquid biopsy

Companies: ANGLE plc

ANGLE CEO reports 'progress across multiple fronts' and talks big new opportunity in immunotherapy

Companies: ANGLE plc

Copyright © 2021 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top